A Win for Small–Cell Lung Cancer: IMPOWER 133
0 Views
administrator
07/14/23
An expert panel comments on the positive results of the IMpower 133 trials, which evaluated the use of carboplatin, etoposide, and atezolizumab in extensive-stage small–cell lung cancer.
-
Category
Show more
Facebook Comments
No comments found